More Evidence Links Roche's Avastin to Heart Failure in Breast Cancer Patients

HealthDay News -- Just weeks after U.S. health officials moved to rescind approval of the drug Avastin to treat breast cancer, a new study provides more evidence that the anti-cancer medication ups the odds of congestive heart failure in these patients.

Back to news